Small and medium sized biotech companies looking to scale up their processes may lose valuable time and money if they don't properly integrate their operations to a new bioreactor.

BioReactor Sciences (BRS) can save tens of thousands of dollars as a research-based total solutions provider from pre-sales assessment, installation assistance, and post-sales technical support.

“We purchased Bioreactor Sciences’ (BRS) MA-150 in 2017 and it has been integral in scaling up production of our membrane protein. BRS’ MA-150 is Metaclipse’s first lab bioreactor and it has proven to be very reliable and intuitive to operate. Their customer service and technical support has been invaluable in assisting us with establishing our SOP for a fed-batch process in less than one month. This verified process has allowed us to successfully develop procedures to manufacture 2 proteins and 2 antibodies. I highly recommend it.”

-Swe, Senior Scientist, Metaclipse Therapeutics

“BioReactor Sciences' MA100 represents an excellent option for bench-scale bioreactor systems when ease-of-entry and fast batch turnaround times are required. With its Program and Setup features, industrial standard components, process automation and tune-ability, routine cultures are stable, robust, and relatively trouble-free compared to similarly or higher priced glass & stainless systems. The MA-100 is an excellent choice for those looking for an easy-to-use and dependable platform for small to medium microbial fermentation.”

-Kevin, Fermentation Specialist, Genesis Biosciences

 

Email us for a no-cost

discovery consultation

 

NEWS

November 2020: BRS won gwinnett chamber small business award 2020.

MAY 2020: Our patent of Automated Bioreactor Sampling and Glucose Monitoring System was granted (US Patent Number 10669520 B2).

fEBRUARY 2020: Our patent of Automatic Multi-tray and Multi-plate Bioreactor Systems for Adherent Cultures (US Patent Number 10590374B2) was granted.

JULY 2019: Our patent of Horizontally Rocked BioReactor System (US Patent Number 10344257) was granted.

OCTOBER 2017: PUBLICATION OF "Techno-Economic Assessment for Integrating Biosorption into Rare Earth Recovery Process" using our Biofilm and AL moving bed bioreactors, in the ACS Sustainable Chemistry & Engineering Journal 2017, 5, 11, 10148-10155.

OCTOBER 2017: BRS signS a collaborative agreement with Caprico Biotechnologies to develop a platform for small to large production scale of Monoclonal and secondary antibodies.

JULy 2017: BRS joinS the LLNL, Duke Univ., Purdue Univ., and NTEC to submit a proposal for DoE funding opportunity #DE-FOA-0001718.

JUNE 2017: BRS acceptS invitation to join as a member of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

MAy 2017: BRS reacheS an agreement with MetaClipse Therapeutics to collaborate and develop a production process to produce specific membrane proteins for novel personalized immunotherapy products.

December 2016: BRS COLLABORATES with the Lawrence Livermore National LabORATORY and Navajo Transitional Energy Co. to submit a proposal of Production of Salable Rare Earth Elements from Domestic U.S. Coal and Coal By-Products for DoE funding #DE-FOA-0001627.

october 2016: BRS acceptS invitation to join Regenerate USA as a member for the US Dept. of Defense's solicitation for the Advanced Tissue Biofabrication Manufacturing Innovation Institute (ATB-MII).

APRIL 2015: BRS signS MOU agreement with the University of Michigan Health System in collaboration of developing a commercial bioreactor system to produce epithelial pop up keratinocyte cells.

OCTOBER 2014: wINS Bioprocess International Conference & Exhibition (Boston), Best Poster Award.

GaBio_MemberWeb2C.jpg